Response to Ponatinib in Patients with Chronic Myeloid Leukaemia (CML), the Tawam (tertiary care referral hospital UAE) Experience
Sign Up to like & getrecommendations! Published in 2017 at "Blood"
DOI: 10.1182/blood.v130.suppl_1.5262.5262
Abstract: CML is a chronic myeloproliferative disorder that is characterized by the presence of Philadelphia chromosome (a translocation between chromosomes 9 and 22). The therapy of CML has evolved over the years from Hydroxyurea to Interferon,… read more here.
Keywords: cml; response; range years; therapy ... See more keywords